Orris

Indiacation of bllod transfusion according to Harrison medicine

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive data from Harrison's 22nd Edition. Let me compile the full answer.

Indications for Blood Transfusion - Harrison's Principles of Internal Medicine (22nd Ed., 2025)

Harrison's Chapter 118 "Transfusion Therapy and Biology" defines transfusion as the use of blood components to prevent or treat anemia, hemorrhage, and bleeding disorders. Occasionally, blood components may also be used to treat infection or relapse of malignant blood diseases after allogeneic hematopoietic transplantation.

1. Red Blood Cell Concentrate (RBCC) Transfusion

General Principles

Harrison's emphasizes evidence-based (restrictive) transfusion practice. Volume expansion alone (without significant anemia) is NOT an indication for RBCC transfusion - crystalloids and colloids are preferred for volume.

Transfusion Thresholds by Clinical Context

Clinical SettingTransfusion Trigger (Hemoglobin)Notes
Critically ill / ICU patients7 g/dL (70 g/L)Large multicenter RCT showed equivalent outcomes at 7 vs 10 g/dL trigger; conservative strategy preferred
Septic shock>7.0 g/dLHigher target may be appropriate with hypoxemia or myocardial ischemia
Acute upper GI bleeding<7 g/dLRestrictive strategy (threshold 7 g/dL) shown to decrease rebleeding and death vs threshold of 9 g/dL
Chemotherapy-associated anemia<8 g/dL (80 g/L)Or when end-organ compromise occurs; target >9 g/dL if underlying coronary artery disease
Aplastic anemia / bone marrow failure~7 g/dL (70 g/L)Target 9 g/dL (90 g/L) if underlying cardiac or pulmonary disease; 2 units every 2 weeks for patients without functioning marrow
Post-cardiac surgery, post-hip surgery~7 g/dLConservative transfusion strategy shows similar outcomes
  • Harrison's Principles of Internal Medicine 22E, Chapter 118 and Chapter on Critical Care

2. Specific Clinical Indications for Transfusion

Sickle Cell Disease (SCD)

Harrison's explicitly lists the major indications for transfusion in SCD (Chapter on Hemoglobin Disorders):
  1. Severe symptomatic anemia
  2. Treatment and prevention of stroke - Transcranial Doppler screening guides prophylactic exchange transfusion in children
  3. Pre-operative optimization - Increase hemoglobin to ~10 g/dL before surgery requiring general anesthesia
  4. Severe acute chest syndrome
  5. Pregnancy with history of complications or fetal loss (sometimes)
"Transfusions should usually be avoided in acute pain episodes and for repair of stable chronic anemia." - Harrison's 22E, p. 819
Automated red cell exchange transfusion is preferred in acute stroke, severe acute chest syndrome, multiorgan failure, or when chronic transfusions are planned.

Thalassemia / Bone Marrow Failure

  • Transfusion-dependent thalassemia: chronic RBCC transfusions to maintain adequate hemoglobin
  • Iron chelation (deferoxamine or deferasirox) should be added around the 50th transfusion to avoid secondary hemochromatosis

Malaria (Severe/Pediatric)

  • Children with very severe anemia (Hb <4 g/dL) and acidotic breathing require immediate blood transfusion
  • In unstable transmission areas, transfusion is often required when Hb ≤3 g/dL on presentation

3. Platelet Concentrate (PC) Transfusion

Prophylactic Platelet Transfusion

  • Goal: maintain platelet count >10,000/µL
  • Risk of gut oozing increases sharply at counts <5,000/µL
  • Used in aplastic anemia, bone marrow failure, post-chemotherapy thrombocytopenia

4. Plasma / Fresh Frozen Plasma

  • Used to prevent or treat bleeding disorders (e.g., coagulopathies, DIC, warfarin reversal)
  • Contains donor antibodies; risk of adverse reactions (TRALI, volume overload) must be weighed

5. Special / Processed Blood Components

ComponentIndication
Irradiated BCsImmunosuppressed patients - prevents transfusion-associated GVHD
CMV-negative BCsAt-risk immunocompromised patients
Leukocyte-reduced BCsReduces febrile non-hemolytic reactions, CMV transmission, alloimmunization
Antigen-matched RBCsMulti-transfused patients (SCD, thalassemia); Rh (C, E) and K matching beyond ABO/RhD
Pathogen-reduced BCsFurther reduces transfusion-transmitted infection risk

Key Principle: Restrictive vs Liberal Transfusion

Harrison's consistently supports the restrictive transfusion strategy (trigger ~7 g/dL), which has been validated across:
  • General ICU patients (TRICC trial)
  • Septic shock patients
  • Post-cardiac surgery patients
  • Post-hip surgery patients
  • Acute upper GI bleeding (NEJM trial showing lower mortality with 7 g/dL trigger vs 9 g/dL)
A liberal strategy (higher trigger, e.g., 8-10 g/dL) may be appropriate in patients with:
  • Active myocardial ischemia or coronary artery disease
  • Symptomatic hypoxemia
  • Underlying significant cardiac or pulmonary disease (aplastic anemia: target 9 g/dL)
Sources: Harrison's Principles of Internal Medicine, 22nd Edition (2025, McGraw Hill) - Chapter 118: Transfusion Therapy and Biology; Chapter on Critical Care Medicine (ICU Anemia); Chapter on Sickle Cell Disease; Chapter on Aplastic Anemia; Chapter on Malaria
This is a shared conversation. Sign in to Orris to start your own chat.